Titan Pharmaceuticals, Inc. Proceeds from Short-term Debt
Titan Pharmaceuticals, Inc. reported Proceeds from Short-term Debt of $750.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2025-01-03.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromShortTermDebt · last filed 2025-01-03
- 2023-09-30: Proceeds from Short-term Debt 9 month $750.00K.
| Period end | Proceeds from Short-term Debt 9 month |
|---|---|
| 2023-09-30 | $750.00K 10-Q · filed 2025-01-03 |